McKesson's Precision Care Companion supports biomarker-driven cancer care with education, technology, and operational assistance, enhancing genomic testing and targeted therapy prescription.

In another sign of the challenges facing gene therapy developers, Pfizer has abandoned its haemophilia B treatment Beqvez in all world markets, saying weak demand made the business non-viable.

Ryoncil's approval marks the end of a mammoth journey for Australian biotech Mesoblast, which saw two earlier marketing applications for the MSC therapy turned down by the FDA in 2020 and 2023 ...

$ 69.055 USD 0.605 0.88% ...

SEE ALSO: Changing the definition of cerebral palsy Examining the most common patterns of pain and symptom management strategies among adults living with cerebral palsy, University of Michigan Health ...

Elton John and Brandi Carlile land first collaborative chart-topper ...

Most of the in-person therapy is provided in local settings that are as easy for people to access such as GP practices, physical health clinics, community settings and voluntary organisations. In ...

Our vision is to innovate and incorporate promising technologies to communicate freely available, high-priority, high-quality content, which accelerates scientific progress and advances heart and ...